Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Suparma Tbk's Total Liabilities for the quarter that ended in Jun. 2026 was Rp1,381,050 Mil.
PT Suparma Tbk's quarterly Total Liabilities
increased
from Dec. 2025 (Rp1,171,645.30 Mil) to Mar. 2026 (Rp1,255,542.18 Mil) and
increased
from Mar. 2026 (Rp1,255,542.18 Mil) to Jun. 2026 (Rp1,381,049.58 Mil).
PT Suparma Tbk's annual Total Liabilities
increased
from Dec. 2023 (Rp984,503.54 Mil) to Dec. 2024 (Rp1,008,005.05 Mil) and
increased
from Dec. 2024 (Rp1,008,005.05 Mil) to Dec. 2025 (Rp1,171,645.30 Mil).
The historical data trend for PT Suparma Tbk's Total Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
PT Suparma Tbk's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Total Liabilities of Rp1,381,050 Mil mean?
PT Suparma Tbk (ISX:SPMA) has a Total Liabilities of Rp1,381,050 Mil as of Jun. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for PT Suparma Tbk and its competitors.
Is PT Suparma Tbk's Total Liabilities too high?
PT Suparma Tbk's current Total Liabilities is Rp1,381,050 Mil. Overall, PT Suparma Tbk has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Suparma Tbk's Total Liabilities compare to SLVM?
PT Suparma Tbk's Total Liabilities of Rp1,381,050 Mil can be compared against companies in the Forest Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Forest Products company?
A good Total Liabilities depends on the Forest Products industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for PT Suparma Tbk and its competitors. PT Suparma Tbk's current Total Liabilities is Rp1,381,050 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Suparma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Suparma Tbk (ISX:SPMA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp186.11, compared to a current price of Rp164.00 — trading 11.9% below its estimated fair value. The current Total Liabilities is Rp1,381,050 Mil. PT Suparma Tbk's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For PT Suparma Tbk (ISX:SPMA), the current Total Liabilities is Rp1,381,050 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Suparma Tbk (ISX:SPMA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Suparma Tbk stock appears to be undervalued.
The current stock price of Rp164.00 is trading 11.9% below its estimated GF Value™ of Rp186.11.
GuruFocus considers PT Suparma Tbk to be Modestly Undervalued.
Key valuation signals for ISX:SPMA:
Total Liabilities: Rp1,381,050 Mil
GF Value™: Rp186.11 vs. price of Rp164.00 (11.9% below fair value)
No single metric tells the full story. See the ISX:SPMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Suparma Tbk is an Indonesia-based company that manufactures paper and paper products. The group manufactured paper and paper wrapping products for the industrial and consumer sectors. The firm offers Laminated Wrapping Kraft, Samson Kraft, MG Paper, Coated Duplex Board, Bathroom Tissue, Carrier Tissue, Industrial Roll Towel, Kitchen Towel, and Other products. Geographically, the firm generates the majority of its revenue from the local market.
79GF Score
Get the complete analysis for ISX:SPMA
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SPMA has been successfully added to your 
